G protein γ7 expression as a new clinicopathological marker in patients with intrahepatic cholangiocarcinoma
G protein γ7 expression as a new clinicopathological marker in patients with intrahepatic cholangiocarcinoma
复制标题
DOI:
10.1001/archsurg.137.2.181
复制
发表时间:
2002-02-01
影响因子:
--
通讯作者:
Mori, M
中科院分区:
文献类型:
--
作者:
Utsunomiya, T;Inoue, H;Mori, M
Hypothesis: The signal alterations mediated by small G proteins such as Ras, Rho, and Rac have been reported in several cancers. The human G protein gamma7 (G-gamma7) gene, which is down-regulated in various digestive organ cancers, was recently identified and cloned. Thus, the G-gamma7-coupled heterotrimeric G proteins may also contribute to carcinogenesis in human cancers.Setting: University hospital and medical institute of bioregulation.Patients and Methods: The clinicopathological significance of G-gamma7 expression in 18 patients with intrahepatic cholangiocarcinoma (IHCC) was examined. The tumor-nontumor ratio of G-gamma7 expression was determined using reverse transcription polymerase chain reaction analysis. To visualize the localization of G-gamma7, an immunohistochemical study was performed.Main Outcome Measure: Clinicopathological significance of G-gamma7 expression in human IHCC.Results: Expression of G-gamma7 messenger RNA was lower in tumor tissue than in the corresponding nontumor tissue in 17 (94%) of 18 patients with IHCC. The mean tumor-nontumor ratio was 0.54. Eleven patients with tumor-nontumor ratios less than 0.5 showed significantly poorer differentiated IHCC than 7 with tumor-nontumor ratios of 0.5 and greater (P